Female Infertility: Current and Emerging Treatments and Management
What unmet needs remain for women suffering from infertility and how will pipeline agents help remedy these struggles? Female Infertility – SWOT... In DRG Blog/ July, 2018 Advances in the Treatment of Rare Diseases
Why 2018 Will be a Breakthrough Year for These Rare Diseases With Rare Disease Day upon us, we highlight critical advances in drug development... In DRG Blog, Niche and Rare Disease/ March, 2018 Are Moderna’s Bets Worth $7.5 Billion?
Moderna Therapeutics has just completed a new $500 million round of funding, raising its market valuation to a staggering $7.5 billion. Even more... In DRG Blog, Niche and Rare Disease/ February, 2018 HPV Vaccine Safety in Japan: Why Numbers Matter
Recently, a study on side effects related to human papillomavirus (HPV) vaccination, which has been an important issue in Japan, was published1... In DRG Blog, Niche and Rare Disease/ August, 2017 Innovative vaccine developments featured at the 2017 Annual Conference for Vaccines Research: Addressing a variety of diseases with substantial unmet need
Despite tremendous successes in infectious disease prevention using standard approaches, effective vaccines have remained elusive for many serious... In DRG Blog, Niche and Rare Disease/ June, 2017